sitagliptin glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research Hypothesised anti-fibrotic mechanisms activated in

P.Gordon-LarsenP.LavieC

Participants were randomly assigned in a 1:1 ratio to receive either semaglutide 50 mg or a placebo once daily for 68 weeks

The winning combo is consistent resistance training, enough daily protein to support muscle protein synthesis, and consistent creatine use

This article summarizes properties of short- and long-acting GLP-1 analogs, and provides useful information to help choose the most appropriate compound for individual patients

Hi, Charles

Evaluation of the clinical efficacy of the treatment of overweight and obesity in type 2 diabetes mellitus by the telemedicine management system based on the Internet of Things technology